| __timestamp | Bristol-Myers Squibb Company | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 31354781 |
| Thursday, January 1, 2015 | 5920000000 | 43445817 |
| Friday, January 1, 2016 | 4940000000 | 66489820 |
| Sunday, January 1, 2017 | 6411000000 | 96886134 |
| Monday, January 1, 2018 | 6345000000 | 153793000 |
| Tuesday, January 1, 2019 | 6148000000 | 148369000 |
| Wednesday, January 1, 2020 | 11143000000 | 151934000 |
| Friday, January 1, 2021 | 10195000000 | 198532000 |
| Saturday, January 1, 2022 | 9509000000 | 112128000 |
| Sunday, January 1, 2023 | 9299000000 | 76192000 |
| Monday, January 1, 2024 | 11159000000 |
Cracking the code
In the competitive world of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Bristol-Myers Squibb Company and TG Therapeutics, Inc. have demonstrated contrasting approaches to R&D investment. Bristol-Myers Squibb, a giant in the industry, has consistently allocated substantial resources, with a peak in 2020 where R&D expenses surged to nearly 150% of their 2014 levels. This reflects their commitment to maintaining a robust pipeline of new therapies. In contrast, TG Therapeutics, a smaller player, has shown a steady increase in R&D spending, peaking in 2021 at over six times their 2014 investment. This growth underscores their aggressive pursuit of innovation despite limited resources. The data from 2014 to 2023 highlights the strategic priorities of these companies, offering insights into their future trajectories in the pharmaceutical landscape.
R&D Spending Showdown: Johnson & Johnson vs Bristol-Myers Squibb Company
Analyzing R&D Budgets: Novartis AG vs Bristol-Myers Squibb Company
Comparing Innovation Spending: Bristol-Myers Squibb Company and Neurocrine Biosciences, Inc.
Bristol-Myers Squibb Company or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bristol-Myers Squibb Company and Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for Ascendis Pharma A/S and TG Therapeutics, Inc.
TG Therapeutics, Inc. or Ultragenyx Pharmaceutical Inc.: Who Invests More in Innovation?
TG Therapeutics, Inc. or Amneal Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for TG Therapeutics, Inc. and Viking Therapeutics, Inc.
Research and Development Expenses Breakdown: TG Therapeutics, Inc. vs Ligand Pharmaceuticals Incorporated